Prescription opioid injection and risk of hepatitis C in relation to traditional drugs of misuse in a prospective cohort of street youth

BMJ Open

Volumn 4, Issue 7, 2014, Pages

  Hadland, Scott E ^a,b   DeBeck, Kora ^c,d   Kerr, Thomas ^c,d   Feng, Cindy ^c,e   Montaner, Julio S ^c,d   Wood, Evan ^c,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ST PAUL S HOSPITAL   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAMORPHINE; HEPATITIS C ANTIBODY; METHAMPHETAMINE; OPIATE; STREET DRUG; NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

ADOLESCENT; ADULT; AGE; ARTICLE; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENDER; HEALTH SERVICE; HEPATITIS C; HUMAN; INFECTION RISK; JUVENILE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCRIPTION; PROSPECTIVE STUDY; SEROCONVERSION; SEXUAL BEHAVIOR; STREET YOUTH; SYRINGE; COMPLICATION; HOMELESS YOUTH; RISK; SUBSTANCE ABUSE; YOUNG ADULT;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; CANADA; COHORT STUDIES; FEMALE; HEPATITIS C; HOMELESS YOUTH; HUMANS; MALE; PRESCRIPTION DRUGS; PROSPECTIVE STUDIES; RISK; STREET DRUGS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84904659368     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-005419     Document Type: Article

References (45)

1. Lavanchy D. The global burden of hepatitis C. Liver Int 2009;29(Suppl 1):74-81.
2. Ly KN, Xing J, Klevens RM, et al. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med 2012;156:271-8.
3. Miller CL, Spittal PM, Frankish JC, et al. HIV and hepatitis C outbreaks among high-risk youth in Vancouver demands a public health response. Can J Public Health 2005;96:107-8. (Pubitemid 40528709)
4. Centers for Disease Control and Prevention (CDC). Hepatitis C virus infection among adolescents and young adults:Massachusetts, 2002-2009. MMWR Morb Mortal Wkly Rep 2011;60:537-41.
5. The State of the World's Children 1997. 1997. http://www.unicef.org/ sowc97/download.htm (accessed 10 Jul 2009).
6. Street youth in Canada: findings from the enhanced surveillance of Canadian street youth, 1999-2003. 2006. http://www.phac-aspc.gc.ca/std-mts/ reports-06/pdf/street-youth-e.pdf (accessed 16 Jun 2009).
7. Hadland SE, Werb D, Kerr T, et al. Childhood sexual abuse and risk for initiating injection drug use: a prospective cohort study. Prev Med 2012;55:500-4.
8. Roy E, Haley N, Leclerc P, et al. Risk factors for hepatitis C virus infection among street youths. CMAJ 2001;165:557-60. (Pubitemid 32881558)
9. CDC. Vital signs: overdoses of prescription opioid pain relievers - United States, 1999-2008. MMWR Morb Mortal Wkly Rep 2011;60:1487-92.
10. Des Jarlais DC, Friedman SR. HIV infection among intravenous drug users: epidemiology and risk reduction. AIDS 1987;1:67-76. (Pubitemid 18013079)
11. Garfein RS, Vlahov D, Galai N, et al. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996;86:655-61. (Pubitemid 26145477)
12. Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012;379:55-70.
13. Highlights of the 2009 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits. 2010. http://www.samhsa.gov/data/2k10/ dawnsr034edhighlights/edhighlights.htm (accessed 20 Feb 2012).
14. Miech R, Bohnert A, Heard K, et al. Increasing use of nonmedical analgesics among younger cohorts in the United States: a birth cohort effect. J Adolesc Health 2013;52:35-41.
15. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. 2013. http://www.samhsa.gov/data/NSDUH/ 2012SummNatFindDetTables/NationalFindings/NSDUHresults2012.htm (accessed 30 Dec 2013).
16. Lankenau SE, Teti M, Silva K, et al. Initiation into prescription opioid misuse amongst young injection drug users. Int J Drug Policy 2012;23:37-44.
17. Roy E, Arruda N, Bourgois P. The growing popularity of prescription opioid injection in downtown Montreal: new challenges for harm reduction. Subst Use Misuse 2011;46:1142-50.
18. Fischer B, Rehm J, Patra J, et al. Changes in illicit opioid use across Canada. CMAJ 2006;175:1385.
19. Shaw SY, Shah L, Jolly AM, et al. Identifying heterogeneity among injection drug users: a cluster analysis approach. Am J Public Health 2008;98:1430-7.
20. Bruneau J, Roy E, Arruda N, et al. The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users. Addiction 2012;107:1318-27.
21. Daniels D, Grytdal S, Wasley A; Centers for Disease C, Prevention. Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveill Summ 2009;58:1-27.
22. Zou S, Tepper M, Giulivi A. Current status of hepatitis C in Canada. Can J Public Health 2000;91(Suppl 1):S10-15, S10-16.
23. Wood E, Montaner JS, Li K, et al. Burden of HIV infection among aboriginal injection drug users in Vancouver, British Columbia. Am J Public Health 2008;98:515-19. (Pubitemid 351354521)
24. Wood E, Stoltz JA, Montaner JSG, et al. Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study. Harm Reduct J 2006;3:18.
25. Marshall BD, Kerr T, Shoveller JA, et al. Homelessness and unstable housing associated with an increased risk of HIV and STI transmission among street-involved youth. Health Place 2009;15:753-60.
26. Hadland SE, Kerr T, Marshall BD, et al. Non-injection drug use patterns and history of injection among street youth. Eur Addict Res 2010;16:91-8.
27. Hagan H, Thiede H, Des Jarlais DC. Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion. Epidemiology 2004;15:543-9. (Pubitemid 40416907)
28. Hahn JA, Page-Shafer K, Lum PJ, et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis 2002;186:1558-64. (Pubitemid 35379631)
29. Shannon K, Kerr T, Marshall B, et al. Survival sex work involvement as a primary risk factor for hepatitis C virus acquisition in drug-using youths in a canadian setting. Arch Pediatr Adolesc Med 2010;164:61-5.
30. Fast D, Small W, Wood E, et al. Coming 'down here': Young people's reflections on becoming entrenched in a local drug scene. Soc Sci Med 2009;21:21.
31. Garfein RS, Doherty MC, Monterroso ER, et al. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18(Suppl 1):S11-19. (Pubitemid 28304463)
32. Miller CL, Johnston C, Spittal PM, et al. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology 2002;36:737-42. (Pubitemid 34977186)
33. Miller CL, Kerr T, Fischer B, et al. Methamphetamine injection independently predicts hepatitis C infection among street-involved youth in a Canadian setting. J Adolesc Health 2009;44:302-4.
34. Hagan H, Pouget ER, Williams IT, et al. Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. J Infect Dis 2010;201:378-85.
35. Thorpe LE, Ouellet LJ, Hershow R, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol 2002;155:645-53. (Pubitemid 34246097)
36. Fennema JS, van Ameijden EJ, Coutinho RA, et al. Validity of self-reported sexually transmitted diseases in a cohort of drug-using prostitutes in Amsterdam: trends from 1986 to 1992. Int J Epidemiol 1995;24:1034-41.
37. Koester S, Heimer R, Baron AE, et al. Re: 'Risk of hepatitis C virus among young adult injection drug users who share injection equipment'. Am J Epidemiol 2003;157:376; author reply 376-378.
38. Marshall BD, Kerr T, Qi J, et al. Public injecting and HIV risk behaviour among street-involved youth. Drug Alcohol Depend 2010;110:254-8.
39. Racz J, Gyarmathy VA, Neaigus A, et al. Injecting equipment sharing and perception of HIV and hepatitis risk among injecting drug users in Budapest. AIDS Care 2007;19:59-66. (Pubitemid 44852410)
40. Kimber J, Copeland L, Hickman M, et al. Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment. BMJ 2010;341:c3172.
41. Woody GE, Poole SA, Subramaniam G, et al. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA 2008;300:2003-11.
42. Hadland SE, Kerr T, Li K, et al. Access to drug and alcohol treatment among a cohort of street-involved youth. Drug Alcohol Depend 2009;101:1-7.
43. Miller CL, Strathdee SA, Li K, et al. A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IUDs). Am J Drug Alcohol Abuse 2007;33:527-36. (Pubitemid 47196705)
44. Miller CL, Strathdee SA, Kerr T, et al. Factors associated with early adolescent initiation into injection drug use: implications for intervention programs. J Adolesc Health 2006;38:462-4.
45. Ochnio JJ, Patrick D, Ho M, et al. Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs. CMAJ 2001;165:293-7. (Pubitemid 32881230)